AI In Precision Medicine: From Predictive Insight To Operational Confidence

By David Berry, manager, data sciences, and Lee Coram, head of Digital Success and Collaboration Office

Precision medicine trials depend on finding the right patients at the right sites, with the right testing already in place. That makes them much harder to plan and run than traditional studies. Many teams still rely on spreadsheets and periodic check-ins that only reveal problems after timelines start to slip. Artificial intelligence (AI) offers a better way, but only if it’s built on clean, connected, well-governed data. Without that foundation, even advanced tools can produce unreliable insights.

Explore how AI can help trial teams move from reacting to delays toward anticipating them. We cover how continuous forecasting can flag slow site activation or stalling enrollment early. It shows how connecting data across labs, biomarker platforms, and other systems reduces manual reconciliation, and why human experts must remain in charge of key decisions. Build a data foundation now that turns AI into earlier, more confident decisions for your complex trials.